TELA BIO INC. - COMMON STOCK

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Reports First Quarter 2024 Financial Results

09 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio to Announce First Quarter 2024 Financial Results

25 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

15 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

08 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

21 3月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

20 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

29 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

23 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

19 1月 2024 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

15 12月 2023 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio to Take Part in Connecting the Dots

05 12月 2023 07:00:00 条件 Nasdaq GlobeNewswire

TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference

16 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 11月 2023 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Reports Third Quarter 2023 Financial Results

09 11月 2023 16:05:01 条件 Nasdaq GlobeNewswire

TELA Bio to Announce Third Quarter 2023 Financial Results

26 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire

TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase

18 9月 2023 16:05:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

16 8月 2023 07:00:00 条件 Nasdaq GlobeNewswire

TELA Bio Reports Second Quarter 2023 Financial Results

09 8月 2023 16:03:00 条件 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 8月 2023 16:02:00 条件 Nasdaq GlobeNewswire